Business
Sources
CNBC
US Top News and Analysis

AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development center in the Chinese capital.

Topics in this Story

Billion
Astrazeneca Invest
Astrazeneca
Investment
Astrazeneca Invest 2.5bn

AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe

Topics in this Story

Related Stories

AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing

AstraZeneca to invest $2.5bn in China after scandal

Ubisoft spins out new unit for Assassin’s Creed and other games, Tencent to take $1.25 billion stake

Ubisoft spins out new unit for Assassin’s Creed and other games, Tencent to take $1.25 billion stake

South Korea's Hyundai announces $21 billion U.S. investment

Binance secures ‘largest investment ever’ in crypto as Abu Dhabi’s MGX pledges $2 billion

South Korea's Hyundai announces $21 billion U.S. investment

Salesforce pledges to invest $1 billion in Singapore over five years in AI push

EU probes BYD plant in Hungary over unfair Chinese subsidies

More from CNBC

Trump's new auto tariffs will likely drive up car prices by thousands of dollars

CoreWeave prices IPO at $40 a share, below expected range

CoreWeave prices IPO at $40 a share, below expected range

ChatGPT's viral image-generation AI is 'melting' OpenAI's GPUs

Trump withdraws nomination of Rep. Elise Stefanik for U.N. ambassador

More in Business

CoreWeave prices IPO at $40 a share, below expected range

CoreWeave prices IPO at $40 a share, below expected range

Head of Amazon’s TV and Film Steps Down

As generative AI bubble fears grow, the ultra low-cost large language model breakthroughs are booming

CNBC's Inside India newsletter: What ails India's manufacturing?